We are live on ! Find out more
PC

Prairiewood Capital Portfolio holdings

AUM $386M
1-Year Est. Return 17.99%
This Fund
S&P 500
This Quarter Est. Return
+5.37%
1 Year Est. Return
+17.99%
3 Year Est. Return
+42.95%
5 Year Est. Return
+34.68%
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$8.11M
Cap. Flow
+$2.63M
Cap. Flow %
2.25%
Top 10 Hldgs %
53.82%
Holding
71
New
7
Increased
27
Reduced
16
Closed
4

Top Buys

Rank Stock Value
1
FNDA icon
Schwab Fundamental US Small Company Index ETF
FNDA
+$899K
2
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$539K
3
PFFD icon
Global X US Preferred ETF
PFFD
+$508K
4
SHM icon
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
+$484K
5
CTRN icon
Citi Trends
CTRN
+$437K

Top Sells

Rank Stock Value
1
MED icon
Medifast
MED
+$914K
2
CHRS icon
Coherus Oncology
CHRS
+$764K
3
WHD icon
Cactus
WHD
+$581K
4
EBIX
Ebix Inc
EBIX
+$323K
5
BKNG icon
Booking.com
BKNG
+$310K

Sector Composition

Rank Sector Weight
1 Healthcare 11.78%
2 Technology 5.47%
3 Industrials 4.67%
4 Financials 4.21%
5 Communication Services 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRN icon
51
Citi Trends
CTRN
$582M
$413K 0.35%
+4,750
New +$437K
QDEL icon
52
QuidelOrtho
QDEL
$1.21B
$410K 0.35%
+3,202
New +$377K
COLL icon
53
Collegium Pharmaceutical
COLL
$1.15B
$407K 0.35%
+17,208
New +$398K
RGR icon
54
Sturm, Ruger & Co
RGR
$616M
$407K 0.35%
+4,526
New +$339K
GIB icon
55
CGI
GIB
$15.1B
$406K 0.35%
4,484
– –
IFLN
56
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$305M
$370K 0.32%
18,920
-310
-2% -$6.02K
VAW icon
57
Vanguard Materials ETF
VAW
$2.99B
$349K 0.3%
1,928
– –
IPG
58
DELISTED
Interpublic Group of Companies
IPG
$330K 0.28%
10,150
-66
-0.6% -$2.11K
VNDA icon
59
Vanda Pharmaceuticals
VNDA
$315M
$324K 0.28%
15,078
-9,711
-39% -$174K
XRX icon
60
Xerox
XRX
$411M
$320K 0.27%
13,626
-5,224
-28% -$126K
MED icon
61
Medifast
MED
$108M
$308K 0.26%
1,090
-3,372
-76% -$914K
MCK icon
62
McKesson
MCK
$96.8B
$293K 0.25%
1,534
-129
-8% -$24.9K
JPM icon
63
JPMorgan Chase
JPM
$937B
$280K 0.24%
1,798
– –
AAPL icon
64
Apple
AAPL
$4.46T
$238K 0.2%
1,740
– –
MD icon
65
Pediatrix Medical
MD
$2.16B
$233K 0.2%
+7,721
New +$228K
ALSN icon
66
Allison Transmission
ALSN
$9.65B
$219K 0.19%
5,508
– –
USNA icon
67
Usana Health Sciences
USNA
$422M
$214K 0.18%
2,088
-239
-10% -$24K
BKNG icon
68
Booking.com
BKNG
$149B
– –
-3,325
Closed -$310K
CHRS icon
69
Coherus Oncology
CHRS
$222M
– –
-52,292
Closed -$764K
WHD icon
70
Cactus
WHD
$5.12B
– –
-18,961
Closed -$581K
EBIX
71
DELISTED
Ebix Inc
EBIX
– –
-10,090
Closed -$323K
1 2
3

Similar funds

THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
SCP
Siena Capital Partners Chicago, Illinois $385M AUM 11.48% 1-Year Est. Return
GAG
Goodman Advisory Group Needham, Massachusetts $385M AUM 23.11% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return

Prairiewood Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Prairiewood Capital held 71 positions worth $117M, up 7.4% from $109M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Prairiewood Capital's Q2 2021 filing shows 7 new, 27 increased, 16 reduced and 4 closed positions. Its largest new stake was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF: 9,749 shares worth $483K. The largest sale was Medifast, an estimated $914K.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Industrials.

  • Prairiewood Capital's largest Q2 2021 buy was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF: 9,749 shares worth $483K.
  • Prairiewood Capital added most to Schwab Fundamental US Small Company Index ETF in Q2 2021, an estimated $899K increase.
  • Prairiewood Capital's biggest Q2 2021 reduction was Medifast, cutting an estimated $914K.
  • Prairiewood Capital fully exited Coherus Oncology in Q2 2021, selling an estimated $764K.
  • Prairiewood Capital's ten largest holdings make up 54% of its $117M portfolio in Q2 2021.
  • Prairiewood Capital opened 7 new positions and closed 4 in Q2 2021.
  • Prairiewood Capital's portfolio value rose 7.4% quarter-over-quarter to $117M.

Based on Prairiewood Capital's 13F filing for Q2 2021, filed 13 Jul 2021.